Purpose: The basic research goal of the current study was to determine the relationship between stressful life events and the appearance and course of psoriasis under the extreme conditions of war. Patients and Methods: A prospective study was made encompassing 181 patients with psoriasis. One half of the patients were soldiers in active duty under war conditions, the other half consisted of civilians who were living in an area that was frequently subject to shelling from across the nearby frontline. Diagnosis was based on clinical picture, patient history, and auxiliary diagnostic methods. The study has been carried out at the University Clinical Center of Tuzla, as a result of the cooperation between the Departments of Dermatology and Psychiatry. Although numerous measurement instruments were used, the present article concentrates on the analysis of stressful life events with standardized instruments such as ‘Five-Stage Rating Scale’, and ‘Social Readjustment Rating Scale’. Severity of the clinical picture was estimated according to the PASI score, a standardized measurement instrument. Results: Stress levels were observed to be very high: 75% of the soldiers scored above 300 points, with 34% even above 500 points. Civilians scored significant lower, but 51% still had scores above 300 points. Stress was found to be strongly correlated to severity of the disease with correlations of 0.862 and 0.773 (Kendall’s tau-b, p < 0.0001) for soldiers and civilians, respectively. Conclusions: In the past, many authors reported correlations between stress and severity of psoriasis. Our findings demonstrate that under extreme circumstances the correlation between severity of psoriasis and the experience of stress is also extremely strong.
Introduction:Psoriasis is a chronic skin ailment, which can be connected with other ailments including dyslipidemia.Examinees and methods:Research included 70 patients affected by psoriasis. Both genders, above 18 years of age. Average age of the respondents was 47.14 (SD= ±15.41), which consisted of 36 men (51.43%) and 34 women (48.57%). The average duration of psoriasis was 15.52 (SD= ±12.54) years.Results:Frequency of dyslipidemia on those affected by psoriasis was 62.85%. Most often it was hypertriglyceridemia (39%) and hypertriglyceridemia with a lowered value of HDL (36%), average age of those affected by psoriasis with dyslipidemia was 48.76 years (SD= ±14.72), and the average duration of the basic disease was 16.15 years (SD= ±12.63), the average values of the PASI score were 16.65. Increase in values of PASI score and dyslipidemia were statistically significantly connected (r=0.41; p=0.0001).Conclusion:Psoriasis is connected with dyslipidemia.
Introduction:Psoriasis is a chronic skin ailment which can be connected with an increased occurrence of other illnesses, including high blood pressure.Examinees and methods:A prospective study has been conducted which included 70 patients affected by psoriasis, both genders, older than 18 years. Average age being 47,14 (SD= ±15,41) years, from that there were 36 men or 51,43 and 34 women or 48,57%. Average duration of psoriasis was 15,52 (SD=±12,54) years.Results:Frequency of high blood pressure in those affected by psoriasis was 54,28%. Average age of the patients with psoriasis and high blood pressure was 53,79 year (SD=±14,15) and average duration of psoriasis was 17,19 years (SD=±13,51). Average values of PASI score were 16,65. Increase in values of PASI score and high blood pressure were statistically highly related (r=0,36, p=0,0001).Conclusion:Psoriasis was related to high blood pressure and there was a correlation between the severity of psoriasis and high blood pressure.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.